Skip to main content
. 2019 Jan 21;20(2):438. doi: 10.3390/ijms20020438

Table 1.

Clinical characteristics of the studied subjects.

Control Obesity Obesity + Metabolic Syndrome p-Value
Number of subjects 25 17 25
Age (years) 23.3 ± 3.1 38.8 ± 8.4 * 40.5 ± 10.3 * <0.001
Age range 18 to 30 22 to 51 22 to 59 nd
Anthropometric data
Height (m) 1.61 ± 0.05 1.55 ± 0.08 * 1.56 ± 0.06 * 0.002
Weight (kg) 55.3 ± 6.4 83.2 ± 14.1 * 86.8 ± 15.1 * <0.001
BMI (kg/m2) 21.4 ± 1.9 34.8 ± 6.1 * 35.8 ± 5.1 * <0.001
WC (cm) 71.4 ± 7.0 96.9 ± 11.1 * 99.6 ± 10.2 * <0.001 a
HC (cm) 92.0 ± 6.7 114.6 ± 11.1 * 115.7 ± 11.8 * <0.001 a
W/H ratio 0.78 ± 0.6 0.85 ± 0.08 * 0.86 ± 0.05 * <0.001 a
Biochemical data
Fasting Glucose (mg/dL) 84.2 ± 5.5 91.6 ± 05.6 104.6 ± 17.5 * <0.001
Triglycerides (mg/dL) 109.4 ± 29.1 102.2 ± 27.0 177.2 ± 69.6 * <0.001
HDL (mg/dL) 60.6 ± 12.4 45.6 ± 11.5 * 42.4 ± 8.4 * <0.001
LDL (mg/dL) 87.4 ± 24.2 102.0 ± 21.1 116.4 ± 23.3 * <0.001 a
Cholesterol (mg/dL) 170.0 ± 26.2 168.0 ± 26.2 194.3 ± 29.0 * 0.002
LDL-c/HDL-c ratio 1.5 ± 0.6 2.5 ± 1.0 * 2.9 ± 0.8 * <0.001 a
C/HDL-c ratio 2.9 ± 0.7 3.9 ± 1.1 * 4.7 ± 1.1 * <0.001
Blood pressure
SBP (mm Hg) 109.3 ± 10.7 122.7 ± 16.6 * 125.4 ± 13.1 * <0.001
DBP (mm Hg) 71.9 ± 10.9 80.2 ± 13.7 85.5 ± 12.7 * 0.003

The results appear like average ± standard deviation. p-value was calculated according to the Kruskal‒Wallis test for non-parametric data except for a ANOVA for parametric data. WC—waist circumference, HC—hip circumference, W/H—waist to hip ratio, HDL—high-density lipoprotein, LDL—low-density lipoprotein, C/HDL—cholesterol to HDL-c ratio, SBP—systolic blood pressure, DBP—diastolic blood pressure, nd—not determined. p < 0.05 are considered statistically significant. *, indicates statistically significant differences with respect to the control group. The significant differences between pair of groups are shown in Table S6.